Active	Status	Sponsor type	Region	Phase	Filter
6 Active 2 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ciurea, Stefan
NCT04816526: Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy	Terminated	2	13	US	Descartes 08	Cartesian Therapeutics	Myeloma Multiple	08/22	11/22
MPCT-012L, NCT05826535: Study of IMPT-314 in R/R Aggressive B-cell NHL	Recruiting	1/2	150	US	IMPT-314	ImmPACT Bio	Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma	06/25	12/29
NCT05905328: Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy	Recruiting	1/2	54	US	CTO1681 10 μg, CTO1681 20 μg, CTO1681 30 μg	CytoAgents, Inc., TFS HealthScience	Cytokine Release Syndrome	06/27	06/27